Gene · 2767
Papers2,923
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,923
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reciprocal positive regulation between BRD4 and YAP in GNAQ-mutant uveal melanoma cells confers sensitivity to BET inhibitors. | Pharmacol Res | 2022 | 36162600 | PubTator, text mining | PubMed |
| Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases. | Case Rep Endocrinol | 2022 | 36160179 | PubTator, text mining | PubMed |
| Etiology and Pathophysiology of Hypoparathyroidism: A Narrative Review. | J Bone Miner Res | 2022 | 36153665 | PubTator, text mining | PubMed |
| FGFR-2 and Epithelial-Mesenchymal Transition in Endometrial Cancer. | J Clin Med | 2022 | 36143062 | PubTator, text mining | PubMed |
| Targeted Next-Generation Sequencing-Based Multiple Gene Mutation Profiling of Patients with Rectal Adenocarcinoma Receiving or Not Receiving Neoadjuvant Chemoradiotherapy. | Int J Mol Sci | 2022 | 36142267 | PubTator, text mining | PubMed |
| Intra-Abdominal Malignant Melanoma: Challenging Aspects of Epidemiology, Clinical and Paraclinical Diagnosis and Optimal Treatment-A Literature Review. | Diagnostics (Basel) | 2022 | 36140455 | PubTator, text mining | PubMed |
| Implications of a Neuronal Receptor Family, Metabotropic Glutamate Receptors, in Cancer Development and Progression. | Cells | 2022 | 36139432 | PubTator, text mining | PubMed |
| Identification of a 5-gene-based signature to predict prognosis and correlate immunomodulators for rectal cancer. | Transl Oncol | 2022 | 36130456 | PubTator, text mining | PubMed |
| ALS-linked loss of Cyclin-F function affects HSP90. | Life Sci Alliance | 2022 | 36114006 | PubTator, text mining | PubMed |
| Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy. | Front Oncol | 2022 | 36106113 | PubTator, text mining | PubMed |
| Distinct gene expression patterns for CD14++ and CD16++ monocytes in preeclampsia. | Sci Rep | 2022 | 36104441 | PubTator, text mining | PubMed |
| Identification of 4 New Loci Associated With Primary Hyperparathyroidism (PHPT) and a Polygenic Risk Score for PHPT. | J Clin Endocrinol Metab | 2022 | 36102151 | PubTator, text mining | PubMed |
| EGFR Mutations and PD-L1 Expression in Early-Stage Non-Small Cell Lung Cancer: A Real-World Data From a Single Center in Brazil. | Oncologist | 2022 | 36099421 | PubTator, text mining | PubMed |
| Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused by biased allosteric CaSR autoantibodies. | JCI Insight | 2022 | 36099030 | PubTator, text mining | PubMed |
| Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes. | Cancer Discov | 2022 | 36098958 | PubTator, text mining | PubMed |
| Financial Distress and Psychological Well-Being During the COVID-19 Pandemic. | Int J Public Health | 2022 | 36090842 | PubTator, text mining | PubMed |
| Off-label use of cinacalcet in pediatric primary hyperparathyroidism: A French multicenter experience. | Front Pediatr | 2022 | 36090548 | PubTator, text mining | PubMed |
| TRPM4 and TRPV2 are two novel prognostic biomarkers and promising targeted therapy in UVM. | Front Mol Biosci | 2022 | 36081847 | PubTator, text mining | PubMed |
| Prevalence of ARID1A Mutations in Cell-Free Circulating Tumor DNA in a Cohort of 71,301 Patients and Association with Driver Co-Alterations. | Cancers (Basel) | 2022 | 36077815 | PubTator, text mining | PubMed |
| Correlation between BAP1 Localization, Driver Mutations, and Patient Survival in Uveal Melanoma. | Cancers (Basel) | 2022 | 36077643 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2767/papers?page=30